Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
NICE guidance recommends regular monitoring of patients on GLP-1 receptor agonists, including assessment of gastrointestinal tolerability, weight changes, and glycaemic control
This affects both hunger signals and the pleasure response to food
Novartis Pluvicto established radioligand therapy as a commercial reality (2022+): Lutetium-177 PSMA-617 (Pluvicto) for metastatic castration-resistant prostate cancer achieved rapid adoption post-2022 launch, validating the peptide receptor radionuclide therapy platform and creating a template for multiple follow-on radioligand therapy programmes
Cleveland Clinic: Hemorrhoids StatPearls: Internal Hemorrhoids American Society of Colon & Rectal Surgeons: Hemorrhoids StatPearls: External Hemorrhoids Hemorrhoids
US$ 25.12
US$ 23.07
US$ 21.86
